Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jul 18, 2024
Date Accepted: Feb 3, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Tablet- and group-based intervention pilot and protocol studies: Multicomponent cognitive stimulation for older adults with mild cognitive impairment
ABSTRACT
Background:
Cognitive stimulation therapy (CST) is a group-based psychological treatment for people with dementia as well as those with mild cognitive impairment (MCI) and is shown to improve both cognition and quality of life. Previous studies have indicated the potential to benefit from the use of technology devices in group interventions.
Objective:
The pilot study aimed to assess the effectiveness of a tablet- and group-based multicomponent CST (MCST) for enhancing cognitive functions among older adults with MCI.
Methods:
Thirty individuals with MCI participated in 10 sessions of the tablet-based MCST group. A subsequent protocol study will compare tablet-based MCST, tablet-based CST, and control groups among 93 individuals with MCI. The study will be assessed by a pre- and post-test evaluation, including computer-based neuropsychological tests and electroencephalography assessment. The effects of several indicators, such as cognitive, behavioral, and emotional, will be analyzed as being indexed by their neurophysiological data.
Results:
The pilot study showed significant cognitive improvement (z = 4.70, p < .01), reduced depression (z =2.99, p < .01), and decreased state anxiety (z = 3.96, p < .01) post-intervention. Quality of life remained unchanged (z = 1.33, p = .19).
Conclusions:
The study is the first tablet-group-based MCST for older adults with MCI in middle-income countries. It will provide deeper insight into participants’ neuropsychological data, thus identifying specific processes underlying physiologically measured positive outcomes. Furthermore, the project will deliver solid and integrative results to mental health professionals in terms of knowledge and guidance for implementing the tablet- and group-based MCST in people with MCI. Clinical Trial: The study has been preregistered in the Thai Clinical Trials Registry (TCTR) (TCTR number: TCTR20230829004).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.